Coagulation profiles and thromboembolic events of bortezomib plus thalidomide and dexamethasone therapy in newly diagnosed multiple myeloma

Improved survival in multiple myeloma and the impact of novel therapies

Shaji Kumar, S. Vincent Rajkumar, Angela Dispenzieri et al. · Blood · 2007 · 2.3K citations · Full text

Medicine, Oncology, Pharmacotherapy +14

Apoptotic signaling induced by immunomodulatory thalidomide analogs in human multiple myeloma cells: therapeutic implications

Nicholas Mitsiades, Constantine S. Mitsiades, Vassiliki Poulaki et al. · Blood · 2002 · 667 citations · Full text

Medicine, Oncology, Pharmacology +17

Proteasome Inhibitors in Cancer Therapy: Lessons from the First Decade

Robert Z. Orlowski, Deborah J. Kuhn · Clinical Cancer Research · 2008 · 582 citations

Medicine, Oncology, Pharmacology +14

Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma

Antonio Palumbo, Maria Teresa Ambrosini, Giulia Benevolo et al. · Blood · 2006 · 181 citations · Full text

Medicine, Hematology, Oncology +12

Epidemiology of venous thromboembolism in a Chinese population

B.L.Y. Cheuk, Grace Cheung, S. W. K. Cheng · British journal of surgery · 2004 · 160 citations · Full text

Medicine, Hematology, Surgery +17